Researchers at the Leslie Dan Faculty of Pharmacy have devised an advanced drug delivery system for the treatment of ovarian cancer. PoLi, developed by Professors Micheline Piquette-Miller and Christine Allen, is an implantable film that destroys cancer cells while minimizing the side-effects of chemotherapy. The small implant, infused with cancer-killing drugs, is inserted directly into a tumour site after surgical removal of primary tumours. It steadily releases the drug over a two-month period, and dissolves naturally – it does not have to be surgically removed. “The PoLi implant has promise in the treatment of other cancers, including head and neck,” says Piquette-Miller. “We are also developing an injectable gel-based implant formulation that could be administered directly to the tumour site without surgery. This could also be used in the treatment of breast and prostate cancers.” PoLi still requires clinical trials, and a possible partnership with industry is being explored through Innovations at U of T.
Recent Posts
Writing in a Tumultuous Time
Téa Mutonji finds creative possibility in the freedom of her youth
Canada’s Next Innovation Leaders
The Schulich Leader Scholarships support talented science undergrads who are interested in entrepreneurship
A Lifeline for an Endangered Language
U of T linguists have partnered with an Indigenous community member to bring the Munsee dialect back from the brink of extinction